FMR LLC - ENDOCYTE INC ownership

ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 82 filers reported holding ENDOCYTE INC in Q1 2017. The put-call ratio across all filers is 0.14 and the average weighting 0.0%.

Quarter-by-quarter ownership
FMR LLC ownership history of ENDOCYTE INC
ValueSharesWeighting
Q3 2018$16,110,000
+30.8%
907,057
+1.7%
0.00%
+100.0%
Q2 2018$12,313,000
+236.1%
892,230
+121.3%
0.00%
Q1 2018$3,664,000
-59.3%
403,131
-80.8%
0.00%
-100.0%
Q4 2017$8,995,000
+161.0%
2,101,715
-14.0%
0.00%
Q3 2017$3,446,000
-35.1%
2,444,092
-31.0%
0.00%
-100.0%
Q2 2017$5,310,000
-41.1%
3,540,203
+0.9%
0.00%0.0%
Q1 2017$9,018,000
+1.5%
3,509,035
+0.7%
0.00%0.0%
Q4 2016$8,885,000
-16.9%
3,484,410
+0.7%
0.00%0.0%
Q3 2016$10,694,000
-4.2%
3,460,740
-0.5%
0.00%
-50.0%
Q2 2016$11,167,000
+0.3%
3,478,712
-3.1%
0.00%0.0%
Q1 2016$11,132,000
-22.4%
3,590,999
+0.4%
0.00%0.0%
Q4 2015$14,338,000
-12.5%
3,575,595
-0.1%
0.00%0.0%
Q3 2015$16,391,000
-17.3%
3,578,915
-6.3%
0.00%
-33.3%
Q2 2015$19,825,000
-35.7%
3,819,873
-22.4%
0.00%
-25.0%
Q1 2015$30,810,000
-2.1%
4,921,723
-1.6%
0.00%0.0%
Q4 2014$31,475,000
+1.3%
5,003,915
-2.1%
0.00%0.0%
Q3 2014$31,062,000
-12.8%
5,108,923
-5.5%
0.00%
-20.0%
Q2 2014$35,616,000
-75.5%
5,404,572
-11.4%
0.01%
-75.0%
Q1 2014$145,200,000
+283.7%
6,098,292
+72.3%
0.02%
+300.0%
Q4 2013$37,846,000
-11.7%
3,540,315
+10.1%
0.01%
-28.6%
Q3 2013$42,880,000
+67.8%
3,216,815
+65.3%
0.01%
+75.0%
Q2 2013$25,552,0001,946,0410.00%
Other shareholders
ENDOCYTE INC shareholders Q1 2017
NameSharesValueWeighting ↓
VHCP Management II, LLC 4,211,302$74,793,00019.97%
VHCP Management III, LLC 600,000$10,656,0008.05%
RA Capital Management 6,196,143$110,043,0005.88%
GREAT POINT PARTNERS LLC 1,606,100$28,524,0004.44%
Avoro Capital Advisors LLC 5,301,718$94,159,0004.32%
Ghost Tree Capital, LLC 1,100,000$19,536,0004.15%
Crosspoint Capital Strategies, LLC 104,573$1,857,0003.04%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,514,084$62,410,0002.24%
NEXTHERA CAPITAL LP 654,532$11,624,0002.23%
EMORY UNIVERSITY 148,628$2,640,0001.73%
View complete list of ENDOCYTE INC shareholders